2|0|Public
50|$|<b>Quazinone</b> (Dozonone) is a {{cardiotonic}} and vasodilator drug {{which was}} developed and marketed in the 1980s {{for the treatment of}} heart disease. It acts as a selective PDE3 inhibitor. It is no longer available.|$|E
40|$|Kam Man Fai Afia. Thesis (M. Phil.) [...] Chinese University of Hong Kong, 2005. Includes bibliographical {{references}} (leaves [195]- 224). Abstracts in English and Chinese. Abstract [...] - p. iAcknowledgement [...] - p. vPublications [...] - p. viAbbreviations [...] - p. viiChapter 1. [...] - Introduction [...] - p. 1 Chapter 1. 1 [...] - The Mast Cell [...] - p. 2 Chapter 1. 1. 1 [...] - Historical Perspective [...] - p. 2 Chapter 1. 1. 2 [...] - Mast Cell Origin and Development [...] - p. 3 Chapter 1. 1. 3 [...] - Mast Cell Heterogeneity [...] - p. 5 Chapter 1. 1. 3. 1 [...] - Rodent Mast Cell Heterogeneity [...] - p. 5 Chapter 1. 1. 3. 2 [...] - Human Mast Cell Heterogeneity [...] - p. 7 Chapter 1. 1. 4 [...] - Mast Cell Mediators [...] - p. 10 Chapter 1. 1. 4. 1 [...] - Preformed Mediators [...] - p. 11 Chapter 1. 1. 4. 2 [...] - Newly Synthesized Lipid Mediators [...] - p. 14 Chapter 1. 1. 4. 3 [...] - Cytokines [...] - p. 16 Chapter 1. 1. 5 [...] - Mast Cell Activation [...] - p. 17 Chapter 1. 1. 5. 1 [...] - Immunological Activation [...] - p. 19 Chapter 1. 1. 5. 1. 1 [...] - FcεIR Activation and Protein Tyrosine Phosphorylation [...] - p. 19 Chapter 1. 1. 5. 1. 2 [...] - Activation of Phospholipases [...] - p. 20 Chapter 1. 1. 5. 1. 3 [...] - The Role of Calcium [...] - p. 22 Chapter 1. 1. 5. 1. 3. 1 [...] - Intracellular Calcium Mobilization [...] - p. 23 Chapter 1. 1. 5. 1. 3. 2 [...] - Calcium Influx [...] - p. 24 Chapter 1. 1. 5. 1. 3. 3 [...] - Mechanisms of Action of Calcium in Mast Cells [...] - p. 28 Chapter 1. 1. 5. 1. 4 [...] - The Role of G-proteins [...] - p. 30 Chapter 1. 1. 5. 1. 5. [...] - The Role of Cylic AMP [...] - p. 33 Chapter 1. 1. 5. 1. 2. 1 [...] - Mechanisms of Action of Cyclic AMP in Mast Cells [...] - p. 36 Chapter 1. 1. 5. 1. 2. 2 [...] - Implications for the Inhibitory Role of Cyclic AMP in Mast Cell Activation [...] - p. 37 Chapter 1. 2 [...] - The Cyclic Nucleotide Phosphodiesterases [...] - p. 39 Chapter 1. 2. 1 [...] - Introduction [...] - p. 39 Chapter 1. 2. 2 [...] - Classification and Structure [...] - p. 41 Chapter 1. 2. 3 [...] - Distribution and Physiological Functions of the Different PDE Families [...] - p. 45 Chapter 1. 2. 4 [...] - Phosphodiesterase Inhibitors [...] - p. 49 Chapter 1. 2. 4. 1 [...] - Non-selective PDE Inhibitors [...] - p. 50 Chapter 1. 2. 4. 2 [...] - Selective PDE Inhibitors [...] - p. 52 Chapter 1. 2. 4. 2. 1 [...] - PDE 1 and PDE 2 Inhibitors [...] - p. 52 Chapter 1. 2. 4. 2. 2 [...] - PDE 3 Inhibitors [...] - p. 53 Chapter 1. 2. 4. 2. 3 [...] - PDE 4 Inhibitors [...] - p. 54 Chapter 1. 2. 4. 2. 4. 1 [...] - PDE 5 Inhibitors [...] - p. 56 Chapter 2. [...] - Materials and Methods [...] - p. 59 Chapter 2. 1 [...] - Materials [...] - p. 60 Chapter 2. 1. 1 [...] - Drugs [...] - p. 60 Chapter 2. 1. 1. 1 [...] - Phosphodiesterase Inhibitors [...] - p. 60 Chapter 2. 1. 1. 2 [...] - Mast Cell Secretagogues [...] - p. 61 Chapter 2. 1. 2 [...] - Materials for Rat Peritoneal Mast Cell Experiments [...] - p. 61 Chapter 2. 1. 2. 1 [...] - Materials for Rat Sensitization [...] - p. 61 Chapter 2. 1. 2. 2 [...] - Materials for Buffers [...] - p. 62 Chapter 2. 1. 2. 3 [...] - Materials for Histamine Assay [...] - p. 62 Chapter 2. 1. 2. 4 [...] - Miscellaneous [...] - p. 63 Chapter 2. 1. 3 [...] - Materials for RBL- 2 H 3 Cell Line Experiments [...] - p. 63 Chapter 2. 1. 3. 1 [...] - Materials for Cell Culture [...] - p. 63 Chapter 2. 1. 3. 2 [...] - Materials for Cell Sensitization and Enzyme Release [...] - p. 64 Chapter 2. 1. 3. 3 [...] - Materials for β-Hexosaminidase Assay [...] - p. 64 Chapter 2. 1. 3. 4 [...] - Miscellaneous [...] - p. 64 Chapter 2. 2 [...] - Rat Peritoneal Mast Cell Experiments [...] - p. 65 Chapter 2. 2. 1 [...] - Preparation of Buffers [...] - p. 65 Chapter 2. 2. 2 [...] - Preparation of Stock Solutions [...] - p. 66 Chapter 2. 2. 2. 1 [...] - Mast Cell Secretagogue Stock Solutions [...] - p. 66 Chapter 2. 2. 2. 2 [...] - Phosphodiesterase Inhibitor Stock Solutions [...] - p. 66 Chapter 2. 2. 3 [...] - Animals and Cell Isolation [...] - p. 71 Chapter 2. 2. 3. 1 [...] - Animals [...] - p. 71 Chapter 2. 2. 3. 2 [...] - Sensitization of Animals [...] - p. 71 Chapter 2. 2. 3. 3 [...] - Cell Isolation [...] - p. 71 Chapter 2. 2. 3. 4 [...] - Cell Purification [...] - p. 72 Chapter 2. 2. 3. 5 [...] - Determination of Cell Number and Viability [...] - p. 73 Chapter 2. 2. 4 [...] - General Protocol for Histamine Release and Histamine Measurement [...] - p. 75 Chapter 2. 2. 4. 1 [...] - Histamine Release [...] - p. 75 Chapter 2. 2. 4. 2 [...] - Spectrofluorometric Determination of Histamine Content [...] - p. 76 Chapter 2. 2. 4. 2. 1 [...] - Manual Histamine Assay [...] - p. 76 Chapter 2. 2. 4. 2. 2 [...] - Automated Histamine Assay [...] - p. 78 Chapter 2. 2. 4. 3 [...] - Calculation of Histamine Levels [...] - p. 78 Chapter 2. 2. 4. 4 [...] - Presentation and Statistics [...] - p. 79 Chapter 2. 3 [...] - RBL- 2 H 3 Cell Line Experiments [...] - p. 80 Chapter 2. 3. 1 [...] - Preparation of Stock Solutions [...] - p. 80 Chapter 2. 3. 2 [...] - Preparation of Materials for Enzyme Release and Assay [...] - p. 81 Chapter 2. 3. 2. 1 [...] - Cell Culture [...] - p. 81 Chapter 2. 3. 2. 2 [...] - Preparation of Cells for β-Hexosaminidase Release Experiments [...] - p. 82 Chapter 2. 3. 2. 3 [...] - β-Hexosaminidase Release [...] - p. 82 Chapter 2. 3. 2. 4 [...] - β-Hexosaminidase Assay [...] - p. 83 Chapter 3. [...] - Effects of Phosphodiesterase Inhibitors on Mediator Release from Rat Mast Cells [...] - p. 84 Chapter 3. 1 [...] - Introduction [...] - p. 85 Chapter 3. 2 [...] - Materials and Methods [...] - p. 87 Chapter 3. 2. 1 [...] - Rat Peritoneal Mast Cells [...] - p. 87 Chapter 3. 2. 1. 1 [...] - Experiments Employing Immunological Stimulus in RPMCs [...] - p. 87 Chapter 3. 2. 1. 2 [...] - Experiments Employing Non-Immunological Stimuli in RPMCs [...] - p. 88 Chapter 3. 2. 2 [...] - Rat Basophilic Leukemia Cells [...] - p. 88 Chapter 3. 3 [...] - Results [...] - p. 89 Chapter 3. 3. 1 [...] - Rat Peritoneal Mast Cells [...] - p. 89 Chapter 3. 3. 1. 1 [...] - Immunologically Activated Rat Peritoneal Mast Cells [...] - p. 89 Chapter 3. 3. 1. 1. 1 [...] - Effects of Non-Selective PDE Inhibitors on Anti-IgE-Mediated Histamine Release from RPMCs [...] - p. 89 Chapter 3. 3. 1. 1. 2 [...] - Effects of Selective PDE 1 and PDE 2 Inhibitors on Anti-IgE- Mediated Histamine Release from RPMCs [...] - p. 90 Chapter 3. 3. 1. 1. 3 [...] - Effects of Selective PDE 3 Inhibitors on Anti-IgE-Mediated Histamine Release from RPMCs [...] - p. 90 Chapter 3. 3. 1. 1. 4 [...] - Effects of Selective PDE 4 Inhibitors on Anti-IgE-Mediated Histamine Release from RPMCs [...] - p. 91 Chapter 3. 3. 1. 1. 5 [...] - Effects of Selective PDE 5 Inhibitors on Anti-IgE-Mediated Histamine Release from RPMCs [...] - p. 91 Chapter 3. 3. 1. 2 [...] - Non-Immunologically Activated Rat Peritoneal Mast Cells [...] - p. 92 Chapter 3. 3. 1. 2. 1 [...] - Effects of Selective PDE Inhibitors on Compound 48 / 80 - Mediated Histamine Release from RPMCs [...] - p. 92 Chapter 3. 3. 1. 2. 2 [...] - Effects of Selective PDE Inhibitors on Histamine Release from RPMCs Stimulated by Calcium Ionophores [...] - p. 93 Chapter 3. 3. 2 [...] - Rat Basophilic Leukemia Cells [...] - p. 93 Chapter 3. 3. 2. 1 [...] - Effects of Non-Selective PDE Inhibitors on Antigen-Mediated β-Hexosaminidase Release from RBL- 2 H 3 Cells [...] - p. 93 Chapter 3. 3. 2. 2 [...] - Effects of Selective PDE Inhibitors on Antigen-Mediated β-Hexosaminidase Release from RBL- 2 H 3 Cells [...] - p. 94 Chapter 3. 4 [...] - Discussion [...] - p. 95 Chapter 3. 4. 1 [...] - Rat Peritoneal Mast Cells [...] - p. 95 Chapter 3. 4. 1. 1 [...] - Immunologically Activated RPMCs [...] - p. 95 Chapter 3. 4. 1. 2 [...] - Non-Immunologically Activated RPMCs [...] - p. 99 Chapter 3. 4. 2 [...] - Rat Basophilic Leukemia Cells [...] - p. 103 Chapter 4. [...] - Combined Effects of Selective Phosphodiesterase Inhibitors on Immunologically Induced Histamine from Rat Mast Cells [...] - p. 143 Chapter 4. 1 [...] - Introduction [...] - p. 144 Chapter 4. 2 [...] - Materials and Methods [...] - p. 144 Chapter 4. 2. 1 [...] - Simultaneous Addition of PDE 3 and PDE 4 Inhibitors [...] - p. 145 Chapter 4. 2. 2 [...] - Sequential Addition of PDE 3 and PDE 4 Inhibitors [...] - p. 145 Chapter 4. 3 [...] - Results [...] - p. 146 Chapter 4. 3. 1 [...] - Effects of the Selective Inhibitors for PDE 3 and PDE 4 Alone: Calculation of the Expected Inhibition Curve [...] - p. 146 Chapter 4. 3. 2 [...] - Effects of the Simultaneous Addition of PDE 3 and PDE 4 Inhibitors on Anti-IgE-Mediated Histamine Release from RPMCs [...] - p. 148 Chapter 4. 3. 2. 1 [...] - Rolipram and Siguazodan [...] - p. 148 Chapter 4. 3. 2. 2 [...] - Ro 20 - 1724 and Siguazodan [...] - p. 149 Chapter 4. 3. 2. 3 [...] - Rolipram and <b>Quazinone</b> [...] - p. 149 Chapter 4. 3. 2. 4 [...] - Ro 20 - 1724 and <b>Quazinone</b> [...] - p. 150 Chapter 4. 3. 3 [...] - Effects of the Sequential Addition of PDE 3 and PDE 4 Inhibitors on Anti-IgE-Mediated Histamine Release from RPMCs [...] - p. 150 Chapter 4. 3. 3. 1 [...] - Rolipram and Siguazodan [...] - p. 150 Chapter 4. 3. 3. 2 [...] - Ro 20 - 1724 and Siguazodan [...] - p. 151 Chapter 4. 3. 3. 3 [...] - Rolipram and <b>Quazinone</b> [...] - p. 151 Chapter 4. 3. 3. 4 [...] - Ro 20 - 1724 and <b>Quazinone</b> [...] - p. 152 Chapter 4. 4 [...] - Discussion [...] - p. 153 Chapter 5. [...] - Future Directions [...] - p. 191 Chapter 5. 1 [...] - Future Directions [...] - p. 192 References [...] - p. 19...|$|E

